The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes

NCT01455441 · Completed

Last updated 2026-05-28

This clinical trial is testing the effects of physical training combined with the medication liraglutide in adults with type 2 diabetes.

Status Completed The study has finished.

Phase Phase 4 Monitors a drug already on the market.

Type Interventional (clinical trial)

Design Randomized, quadruple-blind treatment study

Participants 40 people

Who can join Ages 18–80 · all sexes

Timeline Started 2011-10 · est. completion 2014-06

Where 1 site · Denmark

What this study is testing ClinicalTrials.gov NCT01455441 ↗

Description as written by the study sponsor.

The objective of this study is to investigate the effects of physical training in patients with type 2 diabetes during treatment with the GLP-1 receptor agonist liraglutide (Victoza®) in a 16-weeks double-blinded, randomized placebo-controlled clinical trial. Hypothesis: Physical training leads to better metabolic control in type 2 diabetic patients when training is combined with liraglutide (Victoza®) treatment.

Treatments tested

Training and liraglutide Other
Training and placebo Other

Main thing measured	HbA1c
Sponsor	Tina Vilsboll
Conditions studied	Type 2 Diabetes
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01455441 ↗